George Dakwar

George Dakwar

Company: CureVac

Job title: Director - Formulation Platform


Beyond the Liver: CureVac’s Novel LNP Platform for Spleen Targeting 2:15 pm

Unveiling CureVac’s innovative approach: explore the cutting-edge design of lipid nanoparticle (LNP) formulations tailored for precise spleen targeting Beyond liver-focused delivery: discover how CureVac’s groundbreaking strategy extends the reach of LNPs Gaining valuable perspective by sharing the rationale behind CureVac’s spleen-targeting LNPsRead more

day: Conference Day Two

Panel Discussion: Beyond the Liver: Unleashing the Potential of Next Gen Lipid-Based Therapies 9:00 am

Expanding the scope of lipid-based therapies beyond the liver to address diverse disease targets throughout the body Exploring novel delivery systems and formulations that harness lipid-based technologies for treating extrahepatic disorders with enhanced precision Pioneering the era of personalized medicine by tailoring lipid-based therapies to individual patient profiles, revolutionizing treatment approaches for various medical conditionsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.